| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of protein localization to synapse | 1.00e-04 | 38 | 49 | 3 | GO:1902473 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 1.53e-04 | 8 | 49 | 2 | GO:2000809 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to synapse | 1.53e-04 | 8 | 49 | 2 | GO:1902474 | |
| GeneOntologyBiologicalProcess | terminal button organization | 1.97e-04 | 9 | 49 | 2 | GO:0072553 | |
| GeneOntologyBiologicalProcess | RISC complex assembly | 2.46e-04 | 10 | 49 | 2 | GO:0070922 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 2.46e-04 | 10 | 49 | 2 | GO:0097105 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 2.71e-04 | 53 | 49 | 3 | GO:0016339 | |
| GeneOntologyBiologicalProcess | postsynaptic density protein 95 clustering | 3.00e-04 | 11 | 49 | 2 | GO:0097119 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 3.00e-04 | 11 | 49 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 3.59e-04 | 12 | 49 | 2 | GO:2000807 | |
| Domain | Nlgn | 6.71e-05 | 5 | 49 | 2 | IPR000460 | |
| Domain | Carboxylesterase_B_CS | 5.16e-04 | 13 | 49 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 6.01e-04 | 14 | 49 | 2 | PS00941 | |
| Domain | COesterase | 6.01e-04 | 14 | 49 | 2 | PF00135 | |
| Domain | CarbesteraseB | 6.01e-04 | 14 | 49 | 2 | IPR002018 | |
| Domain | SH3_2 | 1.49e-03 | 86 | 49 | 3 | IPR011511 | |
| Domain | SH3_2 | 1.49e-03 | 86 | 49 | 3 | PF07653 | |
| Domain | SH3 | 2.45e-03 | 216 | 49 | 4 | SM00326 | |
| Domain | SH3 | 2.45e-03 | 216 | 49 | 4 | PS50002 | |
| Domain | SH3_domain | 2.62e-03 | 220 | 49 | 4 | IPR001452 | |
| Domain | Cadherin_CS | 2.93e-03 | 109 | 49 | 3 | IPR020894 | |
| Domain | CADHERIN_1 | 3.24e-03 | 113 | 49 | 3 | PS00232 | |
| Domain | Cadherin | 3.24e-03 | 113 | 49 | 3 | PF00028 | |
| Domain | CADHERIN_2 | 3.33e-03 | 114 | 49 | 3 | PS50268 | |
| Domain | - | 3.33e-03 | 114 | 49 | 3 | 2.60.40.60 | |
| Domain | CA | 3.41e-03 | 115 | 49 | 3 | SM00112 | |
| Domain | Cadherin-like | 3.49e-03 | 116 | 49 | 3 | IPR015919 | |
| Domain | Cadherin | 3.67e-03 | 118 | 49 | 3 | IPR002126 | |
| Domain | - | 6.76e-03 | 47 | 49 | 2 | 3.30.420.10 | |
| Pubmed | Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. | 2.11e-06 | 2 | 51 | 2 | 10892652 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19889999 | ||
| Pubmed | NLGN1 and NLGN2 in the prefrontal cortex: their role in memory consolidation and strengthening. | 2.11e-06 | 2 | 51 | 2 | 29278843 | |
| Pubmed | Developmental expression and subcellular distribution of synaptotagmin 11 in rat hippocampus. | 6.32e-06 | 3 | 51 | 2 | 22960622 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 28607166 | ||
| Pubmed | Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits. | 6.32e-06 | 3 | 51 | 2 | 29100073 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 27473321 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26291161 | ||
| Pubmed | Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses. | 6.32e-06 | 3 | 51 | 2 | 17897391 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16982420 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 17582332 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 27217145 | ||
| Pubmed | 1.03e-05 | 196 | 51 | 5 | 21862448 | ||
| Pubmed | Autism-related deficits via dysregulated eIF4E-dependent translational control. | 1.26e-05 | 4 | 51 | 2 | 23172145 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 32719346 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 30056576 | ||
| Pubmed | Neuroligins Are Selectively Essential for NMDAR Signaling in Cerebellar Stellate Interneurons. | 2.10e-05 | 5 | 51 | 2 | 27581450 | |
| Pubmed | Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. | 2.10e-05 | 5 | 51 | 2 | 15620359 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 28939043 | ||
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 2.10e-05 | 5 | 51 | 2 | 10996085 | |
| Pubmed | Interaction between autism-linked MDGAs and neuroligins suppresses inhibitory synapse development. | 2.10e-05 | 5 | 51 | 2 | 23358245 | |
| Pubmed | 5-HT modulation of a medial septal circuit tunes social memory stability. | 2.10e-05 | 5 | 51 | 2 | 34616037 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 37865312 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 21838267 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 3.15e-05 | 6 | 51 | 2 | 8576240 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 29724786 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 29742426 | ||
| Pubmed | Dystroglycan is a scaffold for extracellular axon guidance decisions. | 3.15e-05 | 6 | 51 | 2 | 30758284 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 19816407 | ||
| Pubmed | Control of excitatory and inhibitory synapse formation by neuroligins. | 5.87e-05 | 8 | 51 | 2 | 15681343 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 5.87e-05 | 8 | 51 | 2 | 30871858 | |
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 34919427 | ||
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 9278515 | ||
| Pubmed | 9.36e-05 | 1285 | 51 | 9 | 35914814 | ||
| Pubmed | 9.58e-05 | 60 | 51 | 3 | 32027825 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 32973045 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 26403076 | ||
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 18840685 | ||
| Pubmed | Translational animal models of autism and neurodevelopmental disorders. | 1.90e-04 | 14 | 51 | 2 | 23226954 | |
| Pubmed | 2.19e-04 | 15 | 51 | 2 | 18227507 | ||
| Pubmed | SOX5 controls the sequential generation of distinct corticofugal neuron subtypes. | 2.19e-04 | 15 | 51 | 2 | 18215621 | |
| Pubmed | Loss of transforming growth factor-beta 2 leads to impairment of central synapse function. | 3.18e-04 | 18 | 51 | 2 | 18854036 | |
| Pubmed | IgSF21 promotes differentiation of inhibitory synapses via binding to neurexin2α. | 3.18e-04 | 18 | 51 | 2 | 28864826 | |
| Pubmed | 3.23e-04 | 407 | 51 | 5 | 12693553 | ||
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 3.71e-04 | 231 | 51 | 4 | 36597993 | |
| Pubmed | 4.35e-04 | 21 | 51 | 2 | 23303943 | ||
| Pubmed | Sequential phases of cortical specification involve Neurogenin-dependent and -independent pathways. | 5.23e-04 | 23 | 51 | 2 | 15229646 | |
| Pubmed | Type II cadherins guide assembly of a direction-selective retinal circuit. | 5.70e-04 | 24 | 51 | 2 | 25126785 | |
| Pubmed | 6.19e-04 | 25 | 51 | 2 | 29158444 | ||
| Pubmed | Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring. | 6.70e-04 | 26 | 51 | 2 | 39152101 | |
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 6.70e-04 | 26 | 51 | 2 | 34848499 | |
| Pubmed | Lamination of the cerebral cortex is disturbed in Gli3 mutant mice. | 7.23e-04 | 27 | 51 | 2 | 18448089 | |
| Pubmed | Tbr1 regulates regional and laminar identity of postmitotic neurons in developing neocortex. | 8.35e-04 | 29 | 51 | 2 | 20615956 | |
| Pubmed | 8.52e-04 | 126 | 51 | 3 | 16284245 | ||
| Pubmed | Genetic interplay between the transcription factors Sp8 and Emx2 in the patterning of the forebrain. | 8.93e-04 | 30 | 51 | 2 | 17470284 | |
| Pubmed | Neurotransmitter release regulated by a MALS-liprin-alpha presynaptic complex. | 8.93e-04 | 30 | 51 | 2 | 16186258 | |
| Pubmed | 9.54e-04 | 31 | 51 | 2 | 12171929 | ||
| Pubmed | Placing the HIRA histone chaperone complex in the chromatin landscape. | 9.54e-04 | 31 | 51 | 2 | 23602572 | |
| Pubmed | 1.02e-03 | 32 | 51 | 2 | 36252997 | ||
| Pubmed | 1.04e-03 | 304 | 51 | 4 | 32235678 | ||
| Pubmed | 1.15e-03 | 34 | 51 | 2 | 34963132 | ||
| Pubmed | Regulation of prefrontal patterning and connectivity by retinoic acid. | 1.15e-03 | 34 | 51 | 2 | 34599305 | |
| Pubmed | 1.22e-03 | 35 | 51 | 2 | 20943929 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.36e-03 | 560 | 51 | 5 | 21653829 | |
| Pubmed | 1.43e-03 | 38 | 51 | 2 | 18579678 | ||
| Pubmed | Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse. | 1.43e-03 | 38 | 51 | 2 | 27930960 | |
| Pubmed | 1.43e-03 | 38 | 51 | 2 | 31080058 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 1.45e-03 | 847 | 51 | 6 | 35235311 | |
| Interaction | LLCFC1 interactions | 1.35e-05 | 121 | 51 | 5 | int:LLCFC1 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.26e-07 | 151 | 51 | 5 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.22e-05 | 158 | 51 | 4 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-05 | 161 | 51 | 4 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.01e-05 | 177 | 51 | 4 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.01e-05 | 177 | 51 | 4 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-05 | 180 | 51 | 4 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.46e-05 | 181 | 51 | 4 | 274c0b768925cd5804483303f8c5ebd17a534c41 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.70e-05 | 183 | 51 | 4 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.82e-05 | 184 | 51 | 4 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 5.95e-05 | 185 | 51 | 4 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.95e-05 | 185 | 51 | 4 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.07e-05 | 186 | 51 | 4 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.07e-05 | 186 | 51 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-05 | 187 | 51 | 4 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-05 | 187 | 51 | 4 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.33e-05 | 188 | 51 | 4 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-05 | 189 | 51 | 4 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-05 | 189 | 51 | 4 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.46e-05 | 189 | 51 | 4 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.46e-05 | 189 | 51 | 4 | 610d7cc1fc923dbd67d3b71f94d529a658982f87 | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 6.59e-05 | 190 | 51 | 4 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-05 | 191 | 51 | 4 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-05 | 192 | 51 | 4 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-05 | 192 | 51 | 4 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.87e-05 | 192 | 51 | 4 | efbd52b3d2b6d3fb9ed6bc3f36aca9f4f1fcbc49 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 7.01e-05 | 193 | 51 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.15e-05 | 194 | 51 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 194 | 51 | 4 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 194 | 51 | 4 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 7.15e-05 | 194 | 51 | 4 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.29e-05 | 195 | 51 | 4 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.44e-05 | 196 | 51 | 4 | efeb272bc9e37e60d15d056b7574991c5c7501bc | |
| ToppCell | COPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 7.73e-05 | 198 | 51 | 4 | 2f13c0b3372af53d1bd85f9546f315c878580a71 | |
| ToppCell | distal-mesenchymal-Myofibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.73e-05 | 198 | 51 | 4 | beef5075ba6dcd4d0a447bc4e57efcaf2e93c546 | |
| ToppCell | Sepsis-URO-Lymphocyte-B-B_intermediate|URO / Disease, condition lineage and cell class | 7.73e-05 | 198 | 51 | 4 | aea2defa941adc8eeee601885cd13817ba108e57 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 7.73e-05 | 198 | 51 | 4 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 7.73e-05 | 198 | 51 | 4 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.89e-05 | 199 | 51 | 4 | f835e7ffe976843b0edbf695762d463da85793f3 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.89e-05 | 199 | 51 | 4 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.89e-05 | 199 | 51 | 4 | 993fa050a095017135a6e723c77cd38b9d782e58 | |
| ToppCell | distal-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.89e-05 | 199 | 51 | 4 | b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.89e-05 | 199 | 51 | 4 | 6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.04e-05 | 200 | 51 | 4 | 93e13937ec74418a697c37d56f57509fb2154780 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-04 | 89 | 51 | 3 | eda156a61e7d14087cfdae5e733d6862834fb0e5 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Rostral-�migratory_stream-�(RMS)_(Stmn2))|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.50e-04 | 90 | 51 | 3 | 7efc3437489c8587b9805547da1095f50d20cf6d | |
| Disease | sulfhydryl oxidase 1 measurement | 8.10e-06 | 3 | 49 | 2 | EFO_0802099 | |
| Disease | lung cancer (implicated_via_orthology) | 9.65e-05 | 9 | 49 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | pain | 3.17e-04 | 196 | 49 | 4 | EFO_0003843 | |
| Disease | migraine without aura, susceptibility to, 4 | 3.19e-04 | 16 | 49 | 2 | MONDO_0011847 | |
| Disease | asthma exacerbation measurement | 5.03e-04 | 93 | 49 | 3 | EFO_0007614 | |
| Disease | visual perception measurement | 5.15e-04 | 223 | 49 | 4 | EFO_0009700 | |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 8.20e-04 | 110 | 49 | 3 | EFO_0003095, MONDO_0005148 | |
| Disease | oppositional defiant disorder measurement | 1.64e-03 | 36 | 49 | 2 | EFO_0007679 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVAPHSPFLLDKFQQ | 576 | Q99814 | |
| RNVKFPPEHPVENDV | 71 | Q9P2B7 | |
| HPNLKPQTTNFREPV | 561 | Q9NY47 | |
| LRSFQETFEKVQPPP | 471 | A1IGU5 | |
| PQAHVDIYEKQPVPF | 61 | P22570 | |
| FHPFAELPEPQQTAL | 296 | O60443 | |
| RPINPHSFEFLINEP | 56 | Q9Y5Z6 | |
| QPPRNITKEPKVFFH | 46 | Q8NEA5 | |
| FRKQLDPFPHRPVQS | 131 | Q86XS5 | |
| VPHQRPSVFQQPVIF | 571 | Q9HCK5 | |
| EPPQRISFKEPHIFS | 101 | A0A1B0GVH7 | |
| QFHKEREQPPRFAQP | 246 | Q15233 | |
| QQSKVSIEVPPEHPF | 531 | P0C7T5 | |
| PHPIPVIFKQQTANR | 116 | Q9UBQ6 | |
| AKPFVPNVHAAEFVP | 56 | Q8IYD1 | |
| IAFVKFPPHDPRQNV | 721 | Q86V87 | |
| PKFPTRVHVQPAVDT | 1236 | Q14315 | |
| PVKGEFHQEFQPEPS | 371 | Q9Y2L9 | |
| PSYQEPHLPRQVFVK | 241 | Q14168 | |
| IQHQLESEKFPPLFP | 686 | Q07864 | |
| DPNQPVPQDTKFIHT | 591 | Q8N2Q7 | |
| FEEVPRETAIQFKPP | 16 | Q5T8I9 | |
| PKDSRENFFPVTVVP | 1931 | Q9Y6J0 | |
| QSGPPHEPRFKFQVV | 526 | P55265 | |
| ERFINHPEFQPAVIK | 2861 | Q8TD57 | |
| PFISDVFQQVEHIPK | 136 | P56159 | |
| PHSPIVEEFQVPYNK | 91 | P09871 | |
| IFAPPQKISHIPENF | 2556 | Q5VT06 | |
| NDPPAFHPQSFIVNK | 391 | Q8IXH8 | |
| DVNDNPPRFPKSIFH | 261 | P55289 | |
| PEFPEHPFQEEHLKQ | 286 | P14735 | |
| VPNLPENFPVSHKDF | 1676 | Q9NYQ7 | |
| FHAAVQRKLPDVPNP | 416 | Q8NFF5 | |
| DPNQPVPQDTKFIHT | 546 | Q8NFZ4 | |
| TLPIQPFVFQHHFPK | 691 | Q8N2Y8 | |
| VKPQHRVPRPDTGFQ | 136 | A4D263 | |
| QTIPPFERPFKDHQV | 206 | Q68CR1 | |
| FRKDFQQINPPHRGP | 856 | Q7Z5M5 | |
| EPSAVLKRHPQPEFF | 361 | Q96QH2 | |
| NPPKRPLIFDTNEFH | 1371 | O14802 | |
| EFEPHIVPSTKNPHQ | 66 | Q15527 | |
| HPQVQKITPNPFRSR | 2141 | Q9P2P6 | |
| PPMFQEDTRKFQVPH | 156 | Q9Y2M2 | |
| ESKHFPNPVKFPNRL | 531 | O60284 | |
| FRHQPRFPKPPNITF | 166 | P60508 | |
| PPEKVQRLYVDFPQH | 11 | P42226 | |
| RPTPQNDAITVHFKP | 361 | Q92545 | |
| FKQSHPEIVNTLFPP | 441 | Q92753 | |
| TVQEPPHFVVKPRDQ | 346 | Q9Y6N7 | |
| VSFPNKPHSEEFQPV | 56 | P35711 | |
| FQIRPVIHFQPTVPM | 496 | Q2M3C6 | |
| REVAAFPLPFVKPEN | 966 | P23378 |